The optimal duration of adjuvant tamoxifen treatment for breast cancer remains uncertain: Randomize into aTTom

Clinical Oncology

Volumn 9, Issue 3, 1997, Pages 141-143

  Earl, H ^a   Gray, R ^a   Kerr, D ^a   Lee, M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; TAMOXIFEN;

BREAST CANCER; CANCER CHEMOTHERAPY; EDITORIAL; ENDOMETRIUM CANCER; GENOTOXICITY; PRIORITY JOURNAL; THROMBOEMBOLISM;

EID: 0030880472     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(97)80067-2     Document Type: Editorial

References (26)